Actions
Houston
,
US
6 - 9 November 2025
American Society of Nephrology (ASN Kidney Week 2025)
Presentation schedule and materials
Thursday, 06 November 2025
10:00
- 12:00
CT
TH-PO0368
POSTER
Kidney, cardiovascular, and death outcomes with semaglutide treatment among two race and two ethnic groups: post hoc analysis from the FLOW trial
Carlos Campos, MD1; Richard Pratley, MD2; Katherine Tuttle, MD3; Sherif Mehanna, MD, MBS4; Caroline Swift, PhD, MPH4; Søren Rasmussen, PhD5; Peter Rossing, DMSc, MD6; Vlado Perkovic, PhD7; Kenneth Mahaffey, MD8; Christian Mende, MD9
MATERIALS AVAILABLE
Coming soon
10:00
- 12:00
CT
TH-PO0363
POSTER
Effect of semaglutide on HbA1c and body weight change by CKD stage: a post hoc analysis from the FLOW trial
Allon N. Friedman, MD1; Richard Pratley, MD2; Katherine Tuttle, MD3; Sherif Mehanna, MD, MBS4; Caroline Swift, PhD, MPH4; Søren Rasmussen, PhD5; Peter Rossing, DMSc, MD6; Vlado Perkovic, PhD7; Kenneth Mahaffey, MD8; Jan Basile, MD9
MATERIALS AVAILABLE
Coming soon
10:00
- 12:00
CT
TH-PO1213
POSTER
PHYOX8: Nedosiran in pediatric patients with primary hyperoxaluria
David J. Sas1,2,3, Sevcan A. Bakkaloglu4, Vladimir Belostotsky5, Gema Ariceta6, Gesa Schalk7, Loai A. Eid8, Jing Yu9, Jyoti Arora9
MATERIALS AVAILABLE
Coming soon
10:00
- 12:00
CT
TH-PO1194
POSTER
Going with the FLOW: Semaglutide and the Risk of Kidney Complications in Early Diabetic Kidney Disease – A Large Registry Study
Genya Aharon-Hananel1,2; Johannes F. Mann3; Alona Aharonovich4; Efrat Leopold5; Gil Chernin2,6
MATERIALS AVAILABLE
Coming soon
Friday, 07 November 2025
10:00
- 12:00
CT
FR-PO0279
POSTER
Evaluating physician preferences for siRNA therapy primary hyperoxaluria type 1 patients
Jing Voon Chen1 , Ambarish Ambegaonkar2, Bhargavi Mahadik2, Nishi Yadav2, Sandra Salem1; presented by Lissette Gutierrez
MATERIALS AVAILABLE
Coming soon
17:10
- 17:20
CT
ORAL PRESENTATION
Discordance between eGFRcystatin C and eGFRcreatinine and cardiovascular risk in the FLOW trial
Inga Soveri1; Johannes F.E. Mann2; Richard Pratley3; Roland E. Schmieder4; David Cherney5; Richard MacIsaac6; Peter Rossing7; Kenneth W. Mahaffey8; L. Sreenivasamurthy9; Srikanth Bellary10,11, Vlado Perkovic12; Soo Kun Lim13; Janusz Gumprecht14; Nicolas Belmar15; Heidrun Bosch-Traberg15; Søren Rasmussen15; Katherine Tuttle16,17; David M. Charytan18
MATERIALS AVAILABLE
Coming soon
Saturday, 08 November 2025
10:00
- 12:00
CT
SA-PO1219
POSTER
Systemic Inflammation and Risk of Adverse Kidney Outcomes in a Veteran Affairs Population With Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease
Kimberly Zitko1; Alexander T. Sandhu2,3; Adam Furst2,3; David J. Maron2; Shriram Nallamshetty2,3; Natasha Din3; Kat Khachatourian1; Jeffrey R. Skaar1; Ivy Tonnu-Mihara1
MATERIALS AVAILABLE
Coming soon
10:00
- 12:00
CT
SA-PO1155
POSTER
Effect of semaglutide on kidney outcomes: Pooled analysis of the SELECT, FLOW, and SOUL trials
Johannes F.E. Mann1; Sunil V. Badve2,3; Florian M.M. Baeres4; Nicolas Belmar4; Kirstine Brown-Frandsen4; John B. Buse5; Helen M. Colhoun6; John E. Deanfield7; Mads D. M. Engelmann4; G. Kees Hovingh4; Thomas Idorn4; A. Michael Lincoff8; Ildiko Lingvay9; Kenneth W. Mahaffey10; Darren K. McGuire11; Richard Pratley12; Søren Rasmussen4; Peter Rossing13; Naveed Sattar14; Katherine Tuttle15,16; Vlado Perkovic3
MATERIALS AVAILABLE
Coming soon
10:00
- 12:00
CT
SA-PO1157
POSTER
FLOW: Effects of semaglutide on kidney failure using the Kidney Failure Risk Equation
L. Sreenivasamurthy1; Mustafa Arici2; Willem A. Bax3; Robert Busch4; Ricardo Correa-Rotter5; José Luis Górriz6; Janusz Gumprecht7; Thomas Idorn8; Kenneth W. Mahaffey9; Johannes F.E. Mann10; Manuel M. Mayrdorfer8; Rikke Baastrup Nordsborg8; Richard Pratley11; Giuseppe Pugliese12; Daniel Guldager Kring Rasmussen8; Peter Rossing13; Navdeep Tangri14; Katherine R. Tuttle15,16; Vlado Perkovic17
MATERIALS AVAILABLE
Coming soon
Actions
Keywords